Navigation Links
New Senior Executives Appointed at Sanofi:
Date:7/22/2011

PARIS, July 22, 2011 /PRNewswire/ -- Sanofi (EURONEXT : SAN ; NYSE : SNY) is pleased to announce today the appointment of Greg Irace, currently President and CEO of Sanofi's US operations, to the newly created role of Senior Vice President, Global Services. In his new role, Greg will lead the Global Information Systems function, be responsible for shared support functions across all Sanofi businesses in North America and play a key role in the development of a global strategy for shared services. Greg will report to Jerome Contamine, Executive Vice President, Chief Financial Officer, and will continue to be a member of the Global Management Committee. He will be based in Bridgewater, New Jersey.

(Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO)

Jerome Contamine, Executive Vice President, Chief Financial Officer, Sanofi, commented: "The integration of Genzyme and Merial gives Sanofi the opportunity to create a platform of shared support functions to serve Sanofi's five North American businesses and its more than 20,000 employees.  I am confident that Greg's dedication and the leadership he has shown in his previous roles will result in his leading this new organization to great success."

Anne C. Whitaker will join Sanofi as President, North America, Pharmaceuticals, effective September 1, 2011.  She will report to Hanspeter Spek, President, Global Operations and will join the Global Management Committee.  She will be based in Bridgewater, New Jersey.

Hanspeter Spek, President, Global Operations, Sanofi, declared: "The knowledge and experience Anne has gained through her previous roles in Sales, Marketing and Leadership Development in the Pharmaceutical industry, particularly in the United States, make her ideally suited to drive the renewed growth of our pharmaceutical operations in North America."

Anne joins Sanofi from GSK, where she was Senior Vice President and Business Unit Head, Cardiovascular, Metabolic and Urology, since 2009.  Anne holds a Bachelors degree in Chemistry and Business Administration from the University of North Alabama.  She began her career at Delta Communications and joined the Upjohn Company in 1991 as a metabolic disease specialist.  She joined GSK in 1992 as a sales representative and held various positions in Sales and Training.  In 2001, she became Vice President of Critical and Supportive Care, a Business Division based in Pennsylvania, before being appointed Senior Vice President of Leadership and Organization Development, based in London, England, from 2008 to 2009.

Greg Irace holds a B.S. in accounting from Albany State University. He began his career at Price Waterhouse in 1980 and received his CPA in 1982. He spent 11 years at Price Waterhouse becoming a Senior Audit Manager in 1988, and a Senior Manager in the Corporate Finance Department in 1989. In 1991, he joined Sterling Winthrop Inc. and became in 1993 Director of Financial Planning and Analysis, and then Chief Financial Officer of Sanofi's Pharmaceutical Operations in the United States in 1994. He has held his current responsibilities for the US operations since 2007.

About SanofiSanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).Contacts:Media RelationsInvestor RelationsJean-Marc Podvin (Paris)

Sebastien MartelTel.: + (33) 1 53 77 46 46

Tel.: + (33) 1 53 77 45 45mr@sanofi.com

ir@sanofi.com Jack Cox (North America)Office: 908-981-5280Jack.Cox@sanofi-aventis.com
'/>"/>

SOURCE Sanofi
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medical Device Consultants, Inc. Welcomes Brian Edwards, Senior Regulatory Staff Consultant
2. Access Pharmaceuticals Announces Restructuring of Outstanding Senior Convertible Note
3. GenturaDx Appoints Senior Vice President of Research & Development
4. Molnlycke Health Care U.S. Announces Senior Management Changes
5. Alere Inc. Announces Completion of Consent Solicitations Related to its 9.0% Senior Subordinated Notes due 2016, 8.625% Senior Subordinated Notes due 2018 and 7.875% Senior Notes due 2016
6. Ferring Pharmaceuticals Inc. Congratulates All 2011 Summer National Senior Games Athletes
7. Senior Executive to Share Views On Physician Payment Sunshine Provisions
8. Alere Inc. Announces Extension of Consent Solicitations Related to its 9.0% Senior Subordinated Notes Due 2016, 8.625% Senior Subordinated Notes Due 2018 and 7.875% Senior Notes Due 2016 and Increased Consent Fees
9. Endo Pharmaceuticals Holdings Inc. Announces Proposed Private Offering of Senior Notes
10. NCPA Urges Congress to Preserve Seniors Access to Diabetes Supplies at Independent Community Pharmacies; Back Schock-Welch Bill
11. Anaphore Appoints Michael F. Haller, Ph.D., Senior Vice President of Strategic Partnerships and H Casey Logan Senior Vice President of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ... in unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as ... premier society for this important science. , The Teratology Society ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, ... strategic partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable ... management of complex spine deformity cases, particularly in children. , GSO’s focus is ...
(Date:4/24/2017)... ... , ... The Santana Telehealth Project was honored with the 2017 ATA Humanitarian ... Association’s annual conference, on April 23 in Orlando, FL. , “I am proud that ... of the poor and underserved in other parts of the world,” said Jonathan Linkous, ...
(Date:4/24/2017)... ... April 24, 2017 , ... The bar for just about everything—apparel, ... inhabiting the rarified air of pop and film stardom.(1) Not to be left out ... the smile. Grins now run the gamut from being encrusted with jewels and precious ...
Breaking Medicine News(10 mins):